Trials / Recruiting
RecruitingNCT06418893
Effect of TCI Propofol on Liver Transplant (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients.
Effect of Isoflurane and Target Control Infusion (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients: A Randomized Controlled Trial.
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Institute of Liver and Biliary Sciences, India · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Both isoflurane and propofol are being used to give anaesthesia for living donor liver transplant in our institute. Propofol when compared to isoflurane has advantages like early awakening from anaesthesia, reduced nausea, vomiting in the postoperative period. Propofol also has antioxidant properties. Because of its antioxidant properties propofol may have a protective effect against oxidative stress and ischemia reperfusion injury in major organs during liver transplant surgery. However, there are no studies showing the effect of isoflurane and propofol on Intraoperative hemodynamics and postoperative liver and kidney functions.Thus, we are conducting this study to know the effect of these agents on intraoperative hemodynamics and postoperative liver and kidney function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Target control infusion propofol | target control infusion of propofol for target plasma concentration 2.5mcg/ml and BIS 40-60 |
| DRUG | Inhalational isoflurane | Inhalational Isoflurane at concentration 1-2% |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2024-10-01
- Completion
- 2024-10-31
- First posted
- 2024-05-17
- Last updated
- 2024-05-17
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT06418893. Inclusion in this directory is not an endorsement.